VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

By E. Gragoudas, A. Adamis, E. Cunningham, M. Feinsod, D. Guyer. 2004

723 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/28e3be853ace93af49b9a62377cdc14b271de50a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Bo-Shiun Lai
2. Yang Zhang
3. Mario Juhas

Citations in the corpus

• Recent Advances in Aptamer Discovery and Applications (2019, background): “A number of aptamers have entered clinical trials, such as for ocular diseases [154] , haematologic diseases [155] , and cancer [156] .”